Fig. 3From: Cuproptosis regulatory genes greatly contribute to clinical assessments of hepatocellular carcinomaCR risk signature provides critical information for prognostic assessment in HCC. A The overall survival difference between high- and low- CR risk groups. B The accuracy of CR risk score and other clinical features for predicting OSR. C The PCA result of CR risk signature. D Cox univariate prognostic analyses. E Cox multivariate prognostic analyses. F The DCA results. Model A (Red) represents clinical stage model. Model B (Blue) represents TNM-staging model. Model C (Orange) represents the survival model consisting of clinical stage and CR risk score. Model D (Green) represents the survival model consisting of TNM stage and CR risk score. G The predictive accuracy of the combination of clinical stage and CR risk score. H The predictive accuracy of the combination of TNM-staging and CR risk score. OSR, overall survival rate; HR, hazard ratio; AUC, area under curve; CI, confidence intervalBack to article page